Bill
SB 33
RIGHT TO TRY INDIVIDUALIZED TREATMENTS ACT
2026 Regular Session
Introduced by Jeff Steinborn and 1 co-sponsor
New Mexico bill would let terminally ill patients access unapproved experimental treatments, bypassing standard FDA approval processes while limiting manufacturer liability.
action postponed indefinitely